பால் சோய் கோல்ட்மேன் சாக்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பால் சோய் கோல்ட்மேன் சாக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பால் சோய் கோல்ட்மேன் சாக்ஸ் Today - Breaking & Trending Today

Global Blood Therapeutics (GBT) Q2 2021 Earnings Call Transcript

Operator
Greetings, and welcome to Global Blood Therapeutics conference call. [Operator instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to Steven Immergut. Please go ahead, sir.
Steven Immergut
Investor Relations
Thank you, and welcome to GBT s conference call to discuss the company s financial results for the second-quarter 2021 and to provide a business update. I m Steven Immergut, head of communications and investor relations. Joining me on the call are Dr. Ted Love, our president and CEO, will provide an update on our progress in the second quarter; Jeff Farrow, our chief financial officer, will review our financial results; David Johnson, or DJ, our chief commercial officer, will give an update on the Oxbryta launch; Dr. ....

United States , United Kingdom , City Of , David Johnson , Jason Gerberry , Kim Smith Whitley , Steven Immergut , Alethia Young , Courtney Roberts , Alethia Young Cantor Fitzgerald , Andrew Berens , Yanan Zhu , Elemer Piros , Paul Choi Goldman Sachs , Mark Breidenbach , Alan Anderson , Baral Cowen , Paul Choi , Jeff Farrow , Goldman Sachs , Kaiser Family Foundation , National Strategic Plan On Sickle Cell Disease , Sickle Cell Disease Association Of America , Mark Breidenbach Oppenheimer Co , National Academies Of Sciences , Company Analyst ,

Myovant Sciences Ltd. (MYOV) Q1 2021 Earnings Call Transcript

Operator
Good day, everyone, and welcome to Myovant Sciences first-quarter of fiscal year 2021 earnings conference call. Today s call is being recorded. At this time, I would like to turn the call over to Ryan Crowe, vice president of investor relations at Myovant. Please go ahead.
Ryan Crowe
Vice President of Investor Relations
Thank you, operator. Good morning and thanks for joining us today to review the financial results of Myovant s first quarter of fiscal year 2021 and to discuss other corporate and business updates. Joining me for today s call are Dave Marek, Myovant s chief executive officer; Frank Karbe, president and chief financial officer; Lauren Merendino, chief commercial officer; and Dr. Juan Camilo Arjona, chief medical officer. ....

Sumitomo Dainippon Pharma , Lauren Merendino , Phil Nadeau Cowen , Josh Schimmer , Jason Butler , Bryan Crowe , Frank Karbe , Juan Camilo , Paul Choi Goldman Sachs , Juan Camilo Arjona , Brian Skorney , Paul Choi , Dave Marek , Phil Nadeau , Deric Joseph , Brian Skorney Baird , Myovant Sciences Ltd , Myovant Sciences , European Commission , Goldman Sachs , Company Analyst , Gedeon Richter , Investor Relations , Withdrawal Study , Liberty Clinical Trial , Liberty Clinical ,

Myovant Sciences Ltd. (MYOV) Q4 2020 Earnings Call Transcript

MYOV earnings call for the period ending March 31, 2021. ....

Sumitomo Dainippon Pharma , Adele Gulfo , Roy Buchanan , Lauren Merendino , Phil Nadeau Cowen , Jason Butler , Bryan Crowe , Frank Karbe , Paul Choi Goldman Sachs , Juan Camilo Arjona , Brian Skorney , Paul Choi , Dave Marek , Mohit Bansal Citi , Phil Nadeau , Deric Joseph , Mohit Bansal , Myovant Sciences , European Commission , Goldman Sachs , Gedeon Richter , Opt Committee , Myovant Sciences Ltd , Company Analyst , New England Journal , Chief Financial ,

Exelixis Inc (EXEL) Q1 2021 Earnings Call Transcript

Operator
Good morning, ladies and gentlemen, and welcome to the Exelixis First Quarter 2021 Financial Results Conference Call. My name is Daphne, and I ll be your operator for today. As a reminder, this call is being recorded for replay purposes.
I would now like to turn the call over to your host for today, Ms. Susan Hubbard, Executive Vice President of Public Affairs and Investor Relations. Please proceed.
Susan T. Hubbard
Executive Vice President, Public Affairs and Investor Relations
Thank you, Daphne, and thank you all for joining us for the Exelixis First Quarter 2021 Financial Results Conference Call. Joining me on today s call are Mike Morrissey, our President and CEO; Chris Senner, our Chief Financial Officer; P.J. Haley, our Executive Vice President of Commercial; and Gisela Schwab, our Chief Medical Officer, who together will review our corporate, financial, commercial and development progress for the first quarter 2021 ended March 31, 2021. Peter ....

United States , Asthika Goodewarne , Andy Hsieh , Stephen Willey , Susan Hubbard , Stephen Willey Stifel , Jason Gerberry , Asthika Goodewarne Truist , Mike Morrissey , Andy Hsieh William Blair , Jay Olson Oppenheimer , Kennen Mackay , Peter Lawson , Michaelm Morrissey , Jay Olson , Yaron Werber , Christopherj Senner , Chris Senner , Akash Tewari , Giselam Schwab , Paul Choi Goldman Sachs , Michael Schmidt Guggenheim , Susant Hubbard , Gabe Daoud Cowen , Gisela Schwab , Paul Choi ,

Global Blood Therapeutics (GBT) Q1 2021 Earnings Call Transcript

Operator
Greetings, and welcome to the Global Blood Therapeutics conference call. [Operator instructions] I would now like to turn the call over to Steven Immergut. Please, go ahead.
Steven Immergut
Senior Vice President, Head of Corporate Communications and Investor Relations
Thank you, and welcome to GBT s conference call to discuss the Company s financial results for the first quarter of 2021 and to provide a business update. I m Steven Immergut, head of communications and investor relations. Joining me on the call are Dr. Ted Love, our president and CEO, who will provide an update on our progress in the first quarter; Jeff Farrow, our chief financial officer, who will review our financial results; David Johnson, or DJ, our chief commercial officer, will give an update on the Oxbryta launch. Ted will then introduce Dr. ....

South Carolina , United States , Canaccord Genuity , David Johnson , Raymond James , John Newman , Jason Gerberry , Andreas Argyrides Wedbush , Kim Smith Whitley , Steven Immergut , Yatin Suneja Guggenheim , Alethia Young , Alethia Young Cantor Fitzgerald , Danielle Brill Raymond James , Xinyue Lu , Yanan Zhu , America Merrill Lynch , Danielle Brill , Gregory Renza , Kim Smith Witley , Ben Burnett , Andreas Argyrides , Akash Tewari , Paul Choi Goldman Sachs , Yatin Suneja , Allen Anderson ,